FirstGene

LAWRENCEVILLE, N.J., July 21, 2026 IMUNON, Inc. has announced positive preliminary Phase 2 minimal residual disease (MRD) clinical data...

SALT LAKE CITY, Utah, July 21, 2026 Myriad Genetics has officially launched the FirstGene® Multiple Prenatal Screen, introducing what...